Latest issue of Clinical laboratory
November 2025
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
Johnson & Johnson acquires Halda Therapeutics for $3.05 billion
, /in E-News /by panglobalJohnson & Johnson has entered into a definitive agreement to acquire Halda Therapeutics OpCo, Inc. for US$3.05 billion in cash, securing access to a clinical-stage prostate cancer therapy and a proprietary platform technology designed to develop oral targeted treatments for solid tumours. The transaction is expected to close within the coming months pending antitrust clearance […]
New AlphaSync database ensures protein structure predictions stay current
, /in E-News /by panglobalSt. Jude Children’s Research Hospital scientists have launched AlphaSync, a free database addressing a critical gap in structural biology by continuously synchronising predicted protein structures with the latest sequence data from UniProt. The resource currently provides 2.6 million updated structural models across 925 species, including disease-relevant proteins previously missing from existing databases.
NADMED launches $30,000 metabolomics competition
, /in E-News /by panglobalA Finnish biotechnology company has opened applications for a global scientific competition designed to advance understanding of cellular redox metabolism, offering successful applicants access to precision measurement technology and expert support valued at up to $30,000.
New Chromsystems Product for Antiepileptic Drugs Testing
, /in Product News /by panglobalChromsystems announces the launch and immediate availability of the MassTox® TDM Series A Parameter Set Antiepileptic Drugs XT2 in Serum/Plasma – All-in-One Method. The updated parameter set extends the MassTox® TDM portfolio, helping laboratories meet clinical needs and regulatory requirements in therapeutic drug monitoring.
Trusted analytical solutions for reliable results
, /in Product News /by panglobalDiscover the perfect solution for every laboratory size. Due to its compact design respons®240c is ideal for small labs that require an analyzer capable of a constant throughput of 240 tests/hour along with intuitively operated software. Advanced features like onboard hemolysis and a grated photometer with 12 wavelengths ensure precision and efficiency.
Chromsystems | Therapeutic Drug Monitoring by LC-MS/MS
, /in Advertenties /by panglobalMassTox® TDM Series A
SHIMADZU | CLAM-2040 goes live with RECIPE TDM platform
, /in Advertenties /by panglobalShimadzu has been paving the way for automated LC-MS/MS (CLAM series) since 2015. Now it’s time for the next step into the future of the clinical laboratory. Discover the IVD kits from the RECIPE ClinMass® TDM platform now available to be used on Shimadzu’s automated IVDR class A solutions for LC-MS/MS! Benefit from LCMS 24/7 […]
DIASYS | ResponsA1C
, /in Advertenties /by panglobalOne step HbA1c analyzer
WERFEN | HIT Testing in Minutes.
, /in Advertenties /by panglobalThe on-demand solution that saves more than time.
Lonza extends TheraPEAK portfolio with AmpliCell cytokines and 293-GT medium for cell and gene therapy manufacturing
, /in Product News /by panglobalLonza has launched two new products to strengthen its offering for cell and gene therapy developers: TheraPEAK AmpliCell Cytokines and TheraPEAK 293-GT Medium. The additions address critical manufacturing requirements for immune cell expansion and adeno-associated virus (AAV) production, respectively.